Search
for
Sort by
Research 121–150 of 528
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Alopecia areata: medical treatments
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Alopecia areata – Current understanding and management
- Immune therapies for alopecia areata: evidence and new perspectives
- Single-Nucleus and Bulk RNA Sequencing Reveals the Involvement of Natural Killer and CD8+ T Cells in the Progression of Androgenetic Alopecia
- Time-course RNA-seq analysis reveals stage-specific and melatonin-triggered gene expression patterns during the hair follicle growth cycle in Capra hircus
- mTOR signaling in hair follicle and hair diseases: recent progress
- Exploring the Potential Role of Hydroxytyrosol in Androgenetic Alopecia: An Integrated Bioinformatics and Molecular Simulation Study
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Implication of microRNA regulation in para-phenylenediamine-induced cell death and senescence in normal human hair dermal papilla cells
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Baricitinib for the Treatment of Alopecia Areata
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- New and Emerging Therapies for Alopecia Areata
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- New Modalities in the Treatment of Refractory Alopecia Areata
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Current and future pharmacotherapy for alopecia areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata